Astrazeneca Plc
- All
- News
- Videos
-
AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
- Tuesday October 11, 2022
- World News | Immanual John Milton, Bloomberg
AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.
- www.ndtv.com
-
Enhertu Sharply Improves Survival In Breast Cancer Patients: Report
- Tuesday June 7, 2022
- World News | James Paton and Robert Langreth, Bloomberg
A drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the lives of patients with an advanced form of breast cancer by about six months in a late-stage trial that may widen the population of people who can benefit from the treatment.
- www.ndtv.com
-
AstraZeneca Booster Significantly Boosts Antibodies Against Omicron
- Thursday December 23, 2021
- World News | Suzi Ring, Bloomberg
A third dose of AstraZeneca Plc's Covid-19 vaccine significantly boosted neutralizing antibody levels against Omicron, according to lab studies at the University of Oxford.
- www.ndtv.com
-
Omicron vs Vaccines Shows What Scientists Fear In New Study
- Tuesday December 14, 2021
- World News | Suzi Ring, Bloomberg
The omicron variant dented the protection afforded by two doses of Pfizer Inc.'s and AstraZeneca Plc's Covid vaccines as feared, researchers found, increasing the risk of infection.
- www.ndtv.com
-
Mixing Covid Vaccines Is Effective In Study on Pfizer, AstraZeneca
- Tuesday December 7, 2021
- World News | Irina Anghel, Bloomberg
Mixing other vaccines with those from AstraZeneca Plc or Pfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a UK study found.
- www.ndtv.com
-
Possible New Links Between AstraZeneca Vaccine And Blood Clots
- Thursday December 2, 2021
- World News | Suzi Ring, Bloomberg
Scientists have identified a possible reason the AstraZeneca Plc Covid-19 vaccine may cause blood clots, after use of the shot was limited globally to prevent the rare side effect.
- www.ndtv.com
-
Covishield, China's Sinovac Approved By Australia Ahead Of Border Opening
- Friday October 1, 2021
- World News | By Angus Whitley, Bloomberg
Australia recognized China's Sinovac Biotech Ltd. COVID-19 shot and India-made AstraZeneca Plc jabs, paving the way for overseas travelers and fee-paying foreign students who have received those vaccinations to enter the country.
- www.ndtv.com
-
Blood Clot Risk Much Higher From Covid Than With Vaccines: UK Study
- Friday August 27, 2021
- World News | Grace Gitau, Bloomberg
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.'s shots, according to a large U.K. study.
- www.ndtv.com
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
- Friday August 20, 2021
- World News | Suzi Ring, Bloomberg
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
- www.ndtv.com
-
Clotting From Covid Shots Is Rare But "Potentially Devastating": Study
- Thursday August 12, 2021
- World News | Grace Gitau, Bloomberg
Researchers say they're making progress in understanding a clotting disorder linked to Covid-19 vaccines that they describe as very rare but potentially "devastating."
- www.ndtv.com
-
EU Should OK Covishield In A Month, Says Maker Adar Poonawalla
- Thursday July 1, 2021
- India News | Malavika Kaur Makol, Bloomberg
The Serum Institute of India expects European drug regulators will approve Covishield -- the Covid-19 shot it manufactures in partnership with AstraZeneca Plc -- in a few weeks, paving way for it to be added to the region's 'Green Pass' list.
- www.ndtv.com
-
Astra Jab Followed By Pfizer, 4 Weeks Apart, Gives Strong Immunity: Study
- Tuesday June 29, 2021
- World News | Katharine Gemmell, Bloomberg
Mixing doses of Covid-19 vaccines from Pfizer Inc. and AstraZeneca Plc creates a strong immune response, according to results from a University of Oxford study, a finding that could enable greater flexibility in the use of scarce supplies.
- www.ndtv.com
-
AstraZeneca Says Its Vaccine Effective Against Variants Identified In India
- Wednesday June 23, 2021
- India News | Reuters
AstraZeneca Plc's COVID-19 vaccine is effective against Delta and Kappa variants, which were first identified in India, the company said on Tuesday, citing a study.
- www.ndtv.com
-
AstraZeneca's Antibody Cocktail Fails to Prevent Covid: Study
- Tuesday June 15, 2021
- World News | Suzi Ring, Bloomberg
AstraZeneca Plc's antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker's pandemic push.
- www.ndtv.com
-
2 AstraZeneca Doses Give Up to 90% Protection From Covid Symptoms: UK
- Friday May 21, 2021
- World News | Todd Gillespie, Bloomberg
Two doses of AstraZeneca Plc's Covid-19 vaccine provide about 85% to 90% protection against symptomatic disease, according to statistics released by Public Health England on Thursday.
- www.ndtv.com
-
AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
- Tuesday October 11, 2022
- World News | Immanual John Milton, Bloomberg
AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.
- www.ndtv.com
-
Enhertu Sharply Improves Survival In Breast Cancer Patients: Report
- Tuesday June 7, 2022
- World News | James Paton and Robert Langreth, Bloomberg
A drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the lives of patients with an advanced form of breast cancer by about six months in a late-stage trial that may widen the population of people who can benefit from the treatment.
- www.ndtv.com
-
AstraZeneca Booster Significantly Boosts Antibodies Against Omicron
- Thursday December 23, 2021
- World News | Suzi Ring, Bloomberg
A third dose of AstraZeneca Plc's Covid-19 vaccine significantly boosted neutralizing antibody levels against Omicron, according to lab studies at the University of Oxford.
- www.ndtv.com
-
Omicron vs Vaccines Shows What Scientists Fear In New Study
- Tuesday December 14, 2021
- World News | Suzi Ring, Bloomberg
The omicron variant dented the protection afforded by two doses of Pfizer Inc.'s and AstraZeneca Plc's Covid vaccines as feared, researchers found, increasing the risk of infection.
- www.ndtv.com
-
Mixing Covid Vaccines Is Effective In Study on Pfizer, AstraZeneca
- Tuesday December 7, 2021
- World News | Irina Anghel, Bloomberg
Mixing other vaccines with those from AstraZeneca Plc or Pfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a UK study found.
- www.ndtv.com
-
Possible New Links Between AstraZeneca Vaccine And Blood Clots
- Thursday December 2, 2021
- World News | Suzi Ring, Bloomberg
Scientists have identified a possible reason the AstraZeneca Plc Covid-19 vaccine may cause blood clots, after use of the shot was limited globally to prevent the rare side effect.
- www.ndtv.com
-
Covishield, China's Sinovac Approved By Australia Ahead Of Border Opening
- Friday October 1, 2021
- World News | By Angus Whitley, Bloomberg
Australia recognized China's Sinovac Biotech Ltd. COVID-19 shot and India-made AstraZeneca Plc jabs, paving the way for overseas travelers and fee-paying foreign students who have received those vaccinations to enter the country.
- www.ndtv.com
-
Blood Clot Risk Much Higher From Covid Than With Vaccines: UK Study
- Friday August 27, 2021
- World News | Grace Gitau, Bloomberg
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.'s shots, according to a large U.K. study.
- www.ndtv.com
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
- Friday August 20, 2021
- World News | Suzi Ring, Bloomberg
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
- www.ndtv.com
-
Clotting From Covid Shots Is Rare But "Potentially Devastating": Study
- Thursday August 12, 2021
- World News | Grace Gitau, Bloomberg
Researchers say they're making progress in understanding a clotting disorder linked to Covid-19 vaccines that they describe as very rare but potentially "devastating."
- www.ndtv.com
-
EU Should OK Covishield In A Month, Says Maker Adar Poonawalla
- Thursday July 1, 2021
- India News | Malavika Kaur Makol, Bloomberg
The Serum Institute of India expects European drug regulators will approve Covishield -- the Covid-19 shot it manufactures in partnership with AstraZeneca Plc -- in a few weeks, paving way for it to be added to the region's 'Green Pass' list.
- www.ndtv.com
-
Astra Jab Followed By Pfizer, 4 Weeks Apart, Gives Strong Immunity: Study
- Tuesday June 29, 2021
- World News | Katharine Gemmell, Bloomberg
Mixing doses of Covid-19 vaccines from Pfizer Inc. and AstraZeneca Plc creates a strong immune response, according to results from a University of Oxford study, a finding that could enable greater flexibility in the use of scarce supplies.
- www.ndtv.com
-
AstraZeneca Says Its Vaccine Effective Against Variants Identified In India
- Wednesday June 23, 2021
- India News | Reuters
AstraZeneca Plc's COVID-19 vaccine is effective against Delta and Kappa variants, which were first identified in India, the company said on Tuesday, citing a study.
- www.ndtv.com
-
AstraZeneca's Antibody Cocktail Fails to Prevent Covid: Study
- Tuesday June 15, 2021
- World News | Suzi Ring, Bloomberg
AstraZeneca Plc's antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker's pandemic push.
- www.ndtv.com
-
2 AstraZeneca Doses Give Up to 90% Protection From Covid Symptoms: UK
- Friday May 21, 2021
- World News | Todd Gillespie, Bloomberg
Two doses of AstraZeneca Plc's Covid-19 vaccine provide about 85% to 90% protection against symptomatic disease, according to statistics released by Public Health England on Thursday.
- www.ndtv.com